The Mediscor Medicines Review 2024 reveals a significant 5.0% increase in medicine expenditure. This marks the most substantial rise in the past three years, presenting a complex challenge for South Africa’s healthcare sector. As a leading pharmaceutical benefits management (PBM) organisation covering over 2.6 million lives, Mediscor’s annual analysis provides a critical barometer for the industry. The 2024 report highlights…